Education
About Us
Working with TipRanks
Follow Us
MCOW - ETF AI Analysis
Top Page
Pacer S&P MidCap 400 Quality FCF Aristocrats ETF (MCOW)
Rating:72Outperform
Price Target:
$22.50
Positive Factors
Strong Top Holdings
Several top holdings, such as Comfort Systems and Medpace Holdings, have delivered strong year-to-date performance, supporting the fund’s overall returns.
Sector Diversification
The ETF is spread across multiple sectors like Technology, Industrials, and Health Care, reducing reliance on any single industry.
Reasonable Expense Ratio
The fund’s expense ratio is competitive compared to actively managed ETFs, keeping costs manageable for investors.
Negative Factors
High Technology Exposure
With over 36% of the portfolio in Technology, the fund is heavily reliant on the performance of this sector, increasing vulnerability to tech market downturns.
Weak Recent Performance
The ETF has shown negative returns year-to-date and over the past month, which may concern investors seeking short-term gains.
Limited Geographic Exposure
The fund is almost entirely focused on U.S. companies, offering little diversification across global markets.
MCOW vs. SPDR S&P 500 ETF (SPY)
AUM994.20K
RegionNorth America
Expense Ratio0.49%
Beta1.13
IssuerPacer
Inception DateAug 27, 2025
Dividend YieldN/A
Asset ClassEquity
Index TrackedS&P MidCap 400 Quality FCF Aristocrats Index - Benchmark TR Gross
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume346
30 Day Avg. Volume1,023
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
23.49Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering81
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
MCOW Summary
The Pacer S&P MidCap 400 Quality FCF Aristocrats ETF (MCOW) is an investment fund that focuses on mid-sized U.S. companies known for generating strong and consistent cash flows. It tracks the S&P MidCap 400 Quality FCF Aristocrats Index, offering exposure to a mix of industries like technology, healthcare, and industrials. Some well-known companies in this ETF include Pure Storage and Medpace Holdings. Investors might consider MCOW for its potential to balance growth and stability while diversifying their portfolio with high-quality mid-cap stocks. However, since it heavily invests in technology and industrials, its performance can be impacted by market trends in those sectors.
How much will it cost me?The Pacer S&P MidCap 400 Quality FCF Aristocrats ETF (MCOW) has an expense ratio of 0.49%, meaning you’ll pay $4.90 per year for every $1,000 invested. This is slightly higher than average for passively managed ETFs, as it focuses on a niche strategy targeting mid-cap companies with strong free cash flow, which requires more specialized tracking.
What would affect this ETF?The MCOW ETF, with its focus on mid-cap companies in the U.S., could benefit from continued innovation and growth in the technology and industrial sectors, which make up a significant portion of its holdings. However, it may face challenges if interest rates rise, as this could increase borrowing costs for mid-sized companies or if economic conditions weaken, impacting consumer spending and business investments. Regulatory changes or sector-specific disruptions in technology or healthcare could also influence the ETF's performance.
MCOW Top 10 Holdings
The MCOW ETF is heavily tilted toward technology and industrials, which together make up over 60% of its portfolio, giving it a clear focus on innovation and infrastructure. Pure Storage and Medpace Holdings are rising stars, driving performance with strong momentum and robust financial results. Comfort Systems is also steady, benefiting from bullish sentiment and strategic growth initiatives. On the flip side, DocuSign and Manhattan Associates are lagging, with mixed technical signals and valuation concerns holding them back. With its U.S.-centric mid-cap focus, the fund offers a blend of growth and stability but remains vulnerable to sector-specific headwinds.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Pure Storage | 5.14% | $51.11K | $29.60B | 70.23% | 76 Outperform | |
| Comfort Systems | 4.53% | $45.02K | $33.69B | 106.74% | 80 Outperform | |
| DocuSign | 4.48% | $44.56K | $14.02B | -12.19% | 72 Outperform | |
| Medpace Holdings | 3.93% | $39.08K | $16.60B | 62.39% | 79 Outperform | |
| Rambus | 3.42% | $33.97K | $11.59B | 93.03% | 78 Outperform | |
| Manhattan Associates | 3.37% | $33.52K | $10.70B | -37.35% | 76 Outperform | |
| Doximity | 2.94% | $29.22K | $10.17B | -6.80% | 70 Outperform | |
| Graco | 2.20% | $21.85K | $13.54B | -7.02% | 70 Outperform | |
| Lattice Semiconductor | 2.19% | $21.82K | $8.68B | 16.43% | 72 Outperform | |
| Qualys | 2.19% | $21.76K | $5.37B | -2.77% | 77 Outperform |
MCOW Technical Analysis
Negative
―
Price Trends
20.35
Negative
Market Momentum
-0.08
Positive
44.23
Neutral
22.03
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For MCOW, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 20.23, equal to the 50-day MA of 20.35, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of -0.08 indicates Positive momentum. The RSI at 44.23 is Neutral, neither overbought nor oversold. The STOCH value of 22.03 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MCOW.
MCOW Peer Comparison
Comparison Results
Performance Comparison
MCOW
Pacer S&P MidCap 400 Quality FCF Aristocrats ETF
19.95
-0.28
-1.38%
AFMC
First Trust Active Factor Mid Cap ETF
―
―
―
CVMC
Calvert US Mid-Cap Core Responsible Index ETF
―
―
―
PAMC
Pacer Lunt MidCap Multi-Factor Alternator ETF
―
―
―
KMID
Virtus KAR Mid-Cap ETF
―
―
―
MMID
MFS Active Mid Cap ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents